gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with singlet oxygen in 1 studies
| Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (singlet oxygen) | Trials (singlet oxygen) | Recent Studies (post-2010) (singlet oxygen) |
|---|---|---|---|---|---|
| 638 | 31 | 243 | 3,870 | 4 | 2,322 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolze, F; Bonnet, CS; Heitz, V; Jenni, S; Pallier, A; Schmitt, J; Sour, A; Tóth, É; Ventura, B | 1 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and singlet oxygen
| Article | Year |
|---|---|
A Porphyrin Dimer-GdDOTA Conjugate as a Theranostic Agent for One- and Two-Photon Photodynamic Therapy and MRI.
Topics: Dimerization; HeLa Cells; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Photochemotherapy; Photons; Photosensitizing Agents; Porphyrins; Singlet Oxygen; Theranostic Nanomedicine | 2018 |